Total Funding
49
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Robin Smith: Founder & CEOPast Role: Seaport Diagnostics, Founder and CEO
Kate Blanchard: Chief Operating Officer / FounderPast Role: PerkinElmer, Business Leader
About the Company
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver, and neurodegenerative indications.
It was founded in 2014 and is based in Boston, Massachusetts.
Women Founded
